Literature DB >> 9266961

Ultraviolet light-induced G2 phase cell cycle checkpoint blocks cdc25-dependent progression into mitosis.

B G Gabrielli1, J M Clark, A K McCormack, K A Ellem.   

Abstract

In response to low doses of ultraviolet (U.V.) radiation, cells undergo a G2 delay. In this study we have shown that the G2 delay results in the accumulation of inactive forms of cyclin B1/cdc2 and both the G2 and mitotic complexes of cyclin A/cdk. This appears to be through a block in the cdc25-dependent activation of these complexes. The expression and localisation of cyclin A and cyclin B1/cdk complexes are similar in U.V.-induced G2 delay and normal early G2 phase cells. Cdc25B and cdc25C also accumulate to normal G2 levels in U.V. irradiated cells, but the mitotic phosphorylation associated with increased activity of both cdc25B and cdc25C is absent. The cdc25B accumulates in the nucleus of U.V. irradiated cells and in normal G2 phase cells. Thus the block in cyclin B/cdc2 activation is in part due to the physical separation of cyclin B/cdc2, localised in the cytoplasm, from the cdc25B and cdc25C phosphatases localised in the nucleus. The data positions the U.V.-induced G2 checkpoint at either the S/G2 transition or early G2 phase, prior to the activation of cyclin A/cdk2.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9266961     DOI: 10.1038/sj.onc.1201254

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

1.  Nuclear export of cyclin B1 and its possible role in the DNA damage-induced G2 checkpoint.

Authors:  F Toyoshima; T Moriguchi; A Wada; M Fukuda; E Nishida
Journal:  EMBO J       Date:  1998-05-15       Impact factor: 11.598

2.  Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cells.

Authors:  L Qiu; A Burgess; D P Fairlie; H Leonard; P G Parsons; B G Gabrielli
Journal:  Mol Biol Cell       Date:  2000-06       Impact factor: 4.138

3.  Human papillomavirus (HPV) E7 induces prolonged G2 following S phase reentry in differentiated human keratinocytes.

Authors:  N Sanjib Banerjee; Hsu-Kun Wang; Thomas R Broker; Louise T Chow
Journal:  J Biol Chem       Date:  2011-02-14       Impact factor: 5.157

4.  MAPK pathway activation delays G2/M progression by destabilizing Cdc25B.

Authors:  Puji Astuti; Tanya Pike; Charlotte Widberg; Elizabeth Payne; Angus Harding; John Hancock; Brian Gabrielli
Journal:  J Biol Chem       Date:  2009-10-01       Impact factor: 5.157

5.  Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression.

Authors:  Jeffrey P Walterscheid; Stephen E Ullrich; Dat X Nghiem
Journal:  J Exp Med       Date:  2002-01-21       Impact factor: 14.307

6.  Cdc25B and Cdc25C differ markedly in their properties as initiators of mitosis.

Authors:  C Karlsson; S Katich; A Hagting; I Hoffmann; J Pines
Journal:  J Cell Biol       Date:  1999-08-09       Impact factor: 10.539

7.  Cdc25B cooperates with Cdc25A to induce mitosis but has a unique role in activating cyclin B1-Cdk1 at the centrosome.

Authors:  Arne Lindqvist; Helena Källström; Andreas Lundgren; Emad Barsoum; Christina Karlsson Rosenthal
Journal:  J Cell Biol       Date:  2005-10-10       Impact factor: 10.539

Review 8.  Phosphatases in Mitosis: Roles and Regulation.

Authors:  Margarida Moura; Carlos Conde
Journal:  Biomolecules       Date:  2019-02-07

9.  ESCRT-III is necessary for the integrity of the nuclear envelope in micronuclei but is aberrant at ruptured micronuclear envelopes generating damage.

Authors:  Jessica Willan; Alexa J Cleasby; Neftali Flores-Rodriguez; Flavia Stefani; Cinzia Rinaldo; Alessandra Pisciottani; Emma Grant; Philip Woodman; Helen E Bryant; Barbara Ciani
Journal:  Oncogenesis       Date:  2019-04-15       Impact factor: 7.485

10.  Entry into mitosis in vertebrate somatic cells is guarded by a chromosome damage checkpoint that reverses the cell cycle when triggered during early but not late prophase.

Authors:  C L Rieder; R W Cole
Journal:  J Cell Biol       Date:  1998-08-24       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.